Cabazitaxel
Sold as Cabitas, Cabazitaxel adco, Xatiza, Xitacab, Cabxel iv, Caphet iv
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 4
- Registrations
- 6
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Accord Healthcare (Pty) Ltd | Cabitas | Not stated | 510326.325 | S4 | None |
| Adcock Ingram Critical Care (Pty) Ltd | Cabazitaxel adco | Not stated | 530360 | S4 | None |
| Lebasi Pharmaceuticals (Pty) Ltd | Xatiza, Xitacab | Not stated | 530361.36, 530362.36 | S4 | None |
| Hetero Drugs South Africa (Pty) Ltd | Cabxel iv, Caphet iv | 60 mg | 560827, 560828.827 | S4 | PIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cabitas EACH 1,0 ml SOLUTION CONTAINS CABAZITAXEL 20,0 mg | Not listed | 510326.32551/26/0326.325 | Registered | S4 | None |
| Cabazitaxel adco EACH 1,5 ml SOLUTION CONTAINS: CABAZITAXEL 60,0 mg | Not listed | 53036053/26/0360 | Registered | S4 | None |
| Xatiza EACH 1,5 ML SOLUTION CONTAINS: CABAZITAXEL 60,0 mg | Not listed | 530361.3653/26/0361.360 | Registered | S4 | None |
| Xitacab EACH 1,5 ML SOLUTION CONTAINS: CABAZITAXEL 60,0 mg | Not listed | 530362.3653/26/0362.360 | Registered | S4 | None |
| Cabxel 60 mg/1,5 ML iv EACH 1,5 ml SOLUTION CONTAINS CABAZITAXEL 60,0 mg | 60 mgConcentrate for solution for infusion | 56082756/26/0827Approved 27 June 2023 | Registered | S4 | PIL |
| Caphet 60 mg/1,5 ML iv EACH 1,5 ml SOLUTION CONTAINS CABAZITAXEL 60,0 mg | 60 mgConcentrate for solution for infusion | 560828.82756/26/0828.827Approved 27 June 2023 | Registered | S4 | PIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Cabazitaxel
S4: Cabazitaxel
Consolidated Schedules 06 July 2026, line 5602
Pharmacological class: Cytostatic agents (class 26)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.